2. Activities, Research and Development (R&D)
Description of Innovation: Development of the proprietary platform AALisi Engine, an infrastructure based on AI algorithms and mmWave radar sensors for the clinical monitoring of vital parameters (HRV, Respiration, Gait Analysis) in a wearable-free mode. The system enables predictive medicine and Health 5.0 models through continuous monitoring (Seamless Monitoring) in complex environments.
R&D Commitment: Pursuant to Art. 25, paragraph 2, letter g) of Decree-Law 179/2012, the company declares a Research and Development expenditure commitment exceeding 20% of the total value of production/investment. Annual R&D investment target: €900,000.00.